Literature DB >> 10474848

A group cognitive behaviour therapy programme with metastatic breast cancer patients.

S Edelman1, D R Bell, A D Kidman.   

Abstract

One-hundred and twenty-four patients with metastatic breast cancer were randomised to either a group Cognitive Behaviour Therapy (CBT) intervention, or to a no-therapy control group condition. Both groups received standard oncological care; however, therapy recipients also attended eight weekly sessions of group CBT, followed by a family night, and three further monthly sessions. Patients completed the 'Profile of Mood States' (POMS) and the Coopersmith Self-esteem Inventory (CSI) before and after therapy, and at 3 and 6 month follow-up periods. Outcome data in the period following therapy showed reduced depression and total mood disturbance, as well as improved self-esteem amongst therapy participants, relative to a no-therapy control group. These improvements were no longer evident at the 3 or 6 month follow-up assessments. We also report on the difficulties associated with conducting a group intervention with this patient cohort.

Entities:  

Mesh:

Year:  1999        PMID: 10474848     DOI: 10.1002/(SICI)1099-1611(199907/08)8:4<295::AID-PON386>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  39 in total

Review 1.  Biobehavioral outcomes following psychological interventions for cancer patients.

Authors:  Barbara L Andersen
Journal:  J Consult Clin Psychol       Date:  2002-06

2.  Cognitive behavioral therapy techniques for distress and pain in breast cancer patients: a meta-analysis.

Authors:  Kristin Tatrow; Guy H Montgomery
Journal:  J Behav Med       Date:  2006-01-07

3.  Benefits of the uncertainty management intervention for African American and White older breast cancer survivors: 20-month outcomes.

Authors:  Karen M Gil; Merle H Mishel; Michael Belyea; Barbara Germino; Laura S Porter; Margaret Clayton
Journal:  Int J Behav Med       Date:  2006

Review 4.  Biobehavioral influences on cancer progression.

Authors:  Erin S Costanzo; Anil K Sood; Susan K Lutgendorf
Journal:  Immunol Allergy Clin North Am       Date:  2011-02       Impact factor: 3.479

Review 5.  Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue.

Authors:  Paul B Jacobsen; Kristine A Donovan; Susan T Vadaparampil; Brent J Small
Journal:  Health Psychol       Date:  2007-11       Impact factor: 4.267

6.  The efficacy of Guolin-Qigong on the body-mind health of Chinese women with breast cancer: a randomized controlled trial.

Authors:  Pei Liu; Jieshu You; Wing T Y Loo; Youzhi Sun; Yanhua He; Huiping Sit; Lei Jia; Meikuen Wong; Zhiyu Xia; Xiao Zheng; Zhiyu Wang; Neng Wang; Lixing Lao; Jianping Chen
Journal:  Qual Life Res       Date:  2017-04-18       Impact factor: 4.147

7.  Pilot randomized controlled trial of individual meaning-centered psychotherapy for patients with advanced cancer.

Authors:  William Breitbart; Shannon Poppito; Barry Rosenfeld; Andrew J Vickers; Yuelin Li; Jennifer Abbey; Megan Olden; Hayley Pessin; Wendy Lichtenthal; Daniel Sjoberg; Barrie R Cassileth
Journal:  J Clin Oncol       Date:  2012-02-27       Impact factor: 44.544

8.  Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial.

Authors:  Barbara L Andersen; William B Farrar; Deanna M Golden-Kreutz; Ronald Glaser; Charles F Emery; Timothy R Crespin; Charles L Shapiro; William E Carson
Journal:  J Clin Oncol       Date:  2004-09-01       Impact factor: 44.544

9.  Meaning-centered group psychotherapy: an effective intervention for improving psychological well-being in patients with advanced cancer.

Authors:  William Breitbart; Barry Rosenfeld; Hayley Pessin; Allison Applebaum; Julia Kulikowski; Wendy G Lichtenthal
Journal:  J Clin Oncol       Date:  2015-02-02       Impact factor: 44.544

Review 10.  Psychosocial interventions for patients with advanced cancer - a systematic review of the literature.

Authors:  R J Uitterhoeve; M Vernooy; M Litjens; K Potting; J Bensing; P De Mulder; T van Achterberg
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.